ArticleJournal of fluorescence2025
Molecular Interaction of the Coumarin Derivative Umbelliferone with Cu/Zn-SOD1 and DNA: Insights into Binding Mode and Antioxidant Mechanism.
Article in Journal of fluorescence, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A member of the coumarin family, umbelliferone is a naturally abundant compound known for its diverse pharmacological and therapeutic properties. Therefore, to gain insight into its molecular recognition mechanism, we plan to conduct an in-depth investigation of its interactions with calf thymus DNA (CT-DNA) and Cu/Zn superoxide dismutase enzyme (SOD1) through a combination of spectroscopic techniques and computational modeling. Results from competitive displacement experiments with EB and Hoechst 33,258, supported by molecular docking analyses, indicate that the umbelliferone preferentially binds to the minor groove of CT-DNA. Using electronic absorption and fluorescence spectroscopy, we confirmed the interaction between the umbelliferone and SOD1, indicating complex formation. The spontaneous nature of the reaction and the stabilization of the complex via van der Waals forces and hydrogen bonding were confirmed through thermodynamic studies. The study revealed that energy transfer takes place efficiently, with a high probability. Microenvironmental and conformational changes in SOD1 were induced by the umbelliferone, as demonstrated by synchronous spectra, 3D fluorescence maps and FTIR analysis. Molecular docking simulations revealed that the umbelliferone preferentially bind to the minor groove of DNA, forming several hydrogen bonds and van der Waals contacts without disrupting the helical structure. In contrast, the compound interacted with a non-catalytic surface region of SOD1, away from the metal-coordinating active site, suggesting a potential allosteric or stabilizing effect rather than direct enzymatic inhibition. The binding affinities were calculated as - 6.32 kcal/mol for DNA and - 5.70 kcal/mol for SOD1. Furthermore, in silico ADMET analyses indicated high gastrointestinal absorption, blood-brain barrier permeability, and a generally favourable pharmacokinetic profile with acceptable toxicity limits. These findings support the dual role of the umbelliferone as a groove-binding DNA stabilizer and a non-covalent modulator of antioxidant enzymes, highlighting its therapeutic relevance in oxidative stress-related conditions. Additionally, the umbelliferone's antioxidant potential was evaluated through the DPPH assay, demonstrating its capacity to scavenge DPPH free radicals.
Indexed as
Identifiers
40824365What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.